Adjuvant Endocrine Therapy-Reference-Cited by-同舟云学术

Adjuvant Endocrine Therapy

Published:2018 Issue: Volume: Page:15-29
ISSN:0927-3042
Container-title:Optimizing Breast Cancer Management
language:
Short-container-title:

Author:

Shah Rena,O’Regan Ruth M.

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-70197-4_2

Reference29 articles.

1. Albain KS et al (2010) Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. The Lancet Oncology 11(1):55–65

2. Anonymous (2010) Pathologists’ guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Breast Care (Basel) 5(3):185–187

3. Breast International Group (BIG) 1-98 Collaborative Group, Thürlimann B et al (2006) A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353(26):2747–2757. Erratum in: N Engl J Med 2006 May 18, 354(20):2200

4. Buus R et al (2016) Comparison of EndoPredict and EPclin with Oncotype DX recurrence score for prediction of risk of distant recurrence after endocrine therapy. J Natl Cancer Inst 108(11)

5. Cardoso F et al (2016) MINDACT investigators. 70-gene signature as an aid to treatment decisions in early-stage breast cancer. N Engl J Med 375(8):717–729

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and antiproliferative activity of raloxifene/histone deacetylase inhibitor hybrids in breast cancer;European Journal of Medicinal Chemistry;2024-08

2. Cancer therapy–related vaginal toxicity: its prevalence and assessment methods—a systematic review;Journal of Cancer Survivorship;2024-02-22

3. Breast cancer: an up‐to‐date review and future perspectives;Cancer Communications;2022-09-08

4. Letrozole Accelerates Metabolic Remodeling through Activation of Glycolysis in Cardiomyocytes: A Role beyond Hormone Regulation;International Journal of Molecular Sciences;2022-01-04

5. FoxO3a Inhibits Tamoxifen-Resistant Breast Cancer Progression by Inducing Integrin α5 Expression;Cancers;2022-01-02